Low disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study

    February 2018 in “ Seminars in Arthritis and Rheumatism ”
    Antonis Fanouriakis, Christina Adamichou, Sofia Koutsoviti, Stylianos Panopoulos, Chrysanthi Staveri, Anastasia Klagou, Christina Tsalapaki, L. Pantazi, Styliani Konsta, Clio P. Mavragani, Despoina Dimopoulou, Styliani Ntali, Georgios Katsikas, Kyriaki Boki, Dimitrios Vassilopoulos, Pinelopi Konstantopoulou, Stamatis‐Nick Liossis, Antonia Elezoglou, Maria G. Tektonidou, Prodromos Sidiropoulos, Abdülsamet Erden, Petros P. Sfikakis, George Βertsias, Dimitrios T. Boumpas

    We don't know much about this study yet.

    We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.
    Discuss this study in the Community →

    Cited in this study

    1 / 1 results

    Related

    1 / 1 results